Aska Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aska Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Nippon Chemiphar Co., Ltd.
sales of 35.69 billion Japanese Yen [US$321.20 million]
of which 97%
was Pharmaceutical Business),
Eiken Chemical Co., Ltd.
(33.27 billion Japanese Yen [US$299.47 million]
of which 54%
was Immunoserology Test Agent), and
Fuso Pharmaceutical Industries Ltd
(46.78 billion Japanese Yen [US$421.04 million]
of which 100%
was Pharmaceutical Business).
Aska Pharmaceutical Company Limited reported sales of ¥48.53 billion (US$436.74 million)
March of 2017.
increase of 12.3%
versus 2016, when the company's sales were ¥43.22 billion.
This was the third consecutive year of growth at Aska Pharmaceutical Company Limited.
Sales of Pharmaceutical Products Business saw an increase
13.2% in 2017, from
¥38.96 billion to ¥44.08 billion.